Learn About Hepatic Hemangioma

What is the definition of Hepatic Hemangioma?

A hepatic hemangioma is a liver mass made of widened (dilated) blood vessels. It is not cancerous.

What are the alternative names for Hepatic Hemangioma?

Liver hemangioma; Hemangioma of the liver; Cavernous hepatic hemangioma; Infantile hemangioendothelioma; Multinodular hepatic hemangiomatosis

What are the causes of Hepatic Hemangioma?

A hepatic hemangioma is the most common type of liver mass that is not caused by cancer. It may be a birth defect.

Hepatic hemangiomas can occur at any time. They are most common in people in their 30s to 50s. Women get these masses more often than men. The masses are often bigger in size.

Babies may develop a type of hepatic hemangioma called benign infantile hemangioendothelioma. This is also known as multinodular hepatic hemangiomatosis. This is a rare, noncancerous tumor that has been linked to high rates of heart failure and death in infants. Infants are most often diagnosed by the time they are 6 months old.

What are the symptoms of Hepatic Hemangioma?

Some hemangiomas may cause bleeding or interfere with organ function. Most do not produce symptoms. In rare cases, the hemangioma may rupture.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hepatic Hemangioma?

Most of these tumors are treated only if there is ongoing pain.

Treatment for infantile hemangioendothelioma depends on the child's growth and development. The following treatments may be needed:

  • Inserting a material in a blood vessel of the liver to block it (embolization)
  • Tying off (ligating) a liver artery
  • Medicines for heart failure
  • Surgery to remove the tumor
Who are the top Hepatic Hemangioma Local Doctors?
Neuroradiology | Radiology | Interventional Radiology
Neuroradiology | Radiology | Interventional Radiology

Kansas University Physicians Inc

10790 Nall Ave, 
Overland Park, KS 
 3.6 mi
Accepting New Patients

Alan Reeves is a Neuroradiologist and a Radiologist in Overland Park, Kansas. Dr. Reeves and is rated as an Experienced provider by MediFind in the treatment of Hepatic Hemangioma. His top areas of expertise are Ascites, Lymphofollicular Hyperplasia, Aseptic and Alopecic Nodules of Scalp (AANS), Thyroidectomy, and Stent Placement. Dr. Reeves is currently accepting new patients.

Ophthalmology
Ophthalmology

Associated Ophthalmologists Of Kansas City, P.C.

1004 Carondelet Dr, 
Kansas City, MO 
 4.8 mi
Accepting New Patients

William White is an Ophthalmologist in Kansas City, Missouri. Dr. White and is rated as an Experienced provider by MediFind in the treatment of Hepatic Hemangioma. His top areas of expertise are Blocked Tear Duct, Entropion, Graves Disease, and Ptosis. Dr. White is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Radiation Oncology
Radiation Oncology

Kansas University Physicians Inc

3901 Rainbow Blvd, 
Kansas City, KS 
 6.2 mi
Accepting New Patients
Offers Telehealth

Fen Wang is a Radiation Oncologist in Kansas City, Kansas. Dr. Wang and is rated as an Advanced provider by MediFind in the treatment of Hepatic Hemangioma. His top areas of expertise are Meningioma, Lung Cancer, Pleuropulmonary Blastoma, and Radiation Induced Meningioma. Dr. Wang is currently accepting new patients.

What is the outlook (prognosis) for Hepatic Hemangioma?

Surgery can cure a tumor in an infant if it is only in one lobe of the liver. This can be done even if the child has heart failure.

What are the possible complications of Hepatic Hemangioma?

Pregnancy and estrogen-based medicines can cause these tumors to grow.

The tumor may rupture in rare cases.

What are the latest Hepatic Hemangioma Clinical Trials?
Clinical Characteristics of Infantile Hemangioma: a Prospective Study

Summary: The primary purpose of this study is to identify the clinical characteristics of infantile hemangioma (IH) in our single center in China. The second objective of the study is to identify the clinical features of infantile hepatic hemangioma (IHH) and ulceration in patients with IHs.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2023
Published By: Michael M. Phillips, MD, Emeritus Professor of Medicine, The George Washington University School of Medicine, Washington, DC. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Cameron J. Liver: management of liver hemangiomas. In: Cameron J, ed. Current Surgical Therapy. 14th ed. Philadelphia, PA: Elsevier; 2023:351-412.

Coleman DM, Mendes BC, Tollefson MM, Bower TC. Pediatric vascular tumors. In: Sidawy AN, Perler BA, eds. Rutherford's Vascular Surgery and Endovascular Therapy. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 187.

Di Bisceglie AM, Befeler AS. Hepatic tumors and cysts. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 96.